Cargando…
Synergy effects of copper ion in doxorubicin-based chelate prodrug for cancer chemo-chemodynamic combination therapy
Doxorubicin (DOX) is a commonly studied chemotherapeutic agent for the treatment of solid tumors, but the severe side effects limit its clinical application. It is shown that DOX-metal chelate has lower in vitro cytotoxicity compared with DOX, as the anthracyclines of DOX can form coordinative inter...
Autores principales: | Zhang, Wen, Zhang, Peng, Xu, Xiaopeng, Li, Minghui, Wang, Shasha, Mu, Hongjie, Sun, Kaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249455/ https://www.ncbi.nlm.nih.gov/pubmed/37282832 http://dx.doi.org/10.1080/10717544.2023.2219426 |
Ejemplares similares
-
Nanosystems for chemodynamic based combination therapy: Strategies and recent advances
por: Li, Minghui, et al.
Publicado: (2022) -
GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo–Chemodynamic Combination Therapy
por: Zhu, Peng, et al.
Publicado: (2021) -
Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy
por: Zhang, Ruiyi, et al.
Publicado: (2022) -
Remodeling of tumor microenvironment for enhanced tumor chemodynamic/photothermal/chemo-therapy
por: Zhang, Ying, et al.
Publicado: (2022) -
Doxorubicin-Loaded Metal-Organic Framework Nanoparticles as Acid-Activatable Hydroxyl Radical Nanogenerators for Enhanced Chemo/Chemodynamic Synergistic Therapy
por: Li, Honghui, et al.
Publicado: (2022)